Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

6.62
Delayed Data
As of Jun 24
 -0.07 / -1.05%
Today’s Change
4.81
Today|||52-Week Range
8.65
-2.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.00500.0K12.4M28.8M
 
 
 
 
Cost of Goods Sold0.00--1.7M4.3M
 
 
 
Depreciation And Amortization9.3K12.5K13.7K6.4K
 
 
 
 
 
 
Operating ExpensesGross Income-9.3K--10.7M24.6M
 
 
 
 
General Expenses8.2M15.3M11.7M13.6M
 
 
 
 
 
Research And Development4.5M8.4M3.3M4.6M
 
 
 
 
 
Total Operating Expenses8.2M15.3M13.4M17.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-14.8M-987.8K11.0M
 
 
 
 
 
Extraordinary Credit0.000.0052.7K36.7K
 
 
 
Other Expenses343.7K343.7K290.5K413.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.8M-14.5M-644.5K11.4M
 
 
 
 
 
Income Taxes0.000.000.00-449.7K
 
 
Net Income-7.8M-14.5M-644.5K11.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.6M102.7M102.7M102.9M
 
 
 
 
 
Shares To Calculate EPS Diluted102.6M102.7M102.7M105.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.14-$0.01$0.10
 
 
 
 
 
EPS Diluted-$0.08-$0.14-$0.01$0.10